Nippon India Mutual Fund trimmed its stake in Pfizer Limited from 4.17% to 4.11%, selling 25,704 shares.
A multinational pharmaceutical manufacturer engaged in producing, marketing, trading, and exporting medicines across India through both owned facilities and contract manufacturers positioned nationwide. The company distributes its products via independent distributors and maintains a significant presence in the domestic pharmaceutical market. Its operations span multiple therapeutic areas serving healthcare needs across the country.
India's fifth-largest AMC with over Rs 6 lakh crore in AUM, backed by Japan's Nippon Life Insurance which holds majority stake. Formerly Reliance MF, rebranded in 2019 after Nippon's acquisition. Sailesh Raj Bhan has run the equity book for over two decades and is one of India's most experienced active managers. Known for sector rotational calls and a deep research bench.
